RekrutujeFaza III
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated…
Miasta: Olsztyn, Poznań, Rzeszów, Warszawa i 1 inne miastoWiek: od 18 latSponsor: AbbVie Deutschland GmbH & Co. KG
Rekrutuje
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Miasta: Gdańsk, OlsztynWiek: od 18 latSponsor: European Organisation for Research and Treatment of Cancer…
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza I
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Miasta: Gdańsk, Kraków, Olsztyn, Tomaszów Mazowiecki i 1 inne miastoWiek: od 18 latSponsor: AstraZeneca AB
RekrutujeFaza II/III
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Miasta: Gdańsk, Kielce, Kraków, Lublin i 6 innych miastWiek: od 18 latSponsor: Mirati Therapeutics Inc.
Rekrutacja wkrótceFaza III
A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in…
Miasta: Olsztyn, Poznań, WarszawaWiek: od 18 latSponsor: AstraZeneca AB